Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, June 2013

Sort by: Newest first Oldest first A-Z Z-A

  • I am a pharmacist?

    30 JUN 2013 By Christopher McDowell

    June 30th 2013Every pre-registration student will understand what I mean, when I say that for the past few days, I have experienced what can only be described as pharmaceutical purgatory... It has been a long and difficult year. The exam is over and the results are in. Maybe you were wildly confident and rushed to type in your exam number on the PSNI website. For myself however, I found myself pacing around the room, hyperventilating, hands tingling whilst repeating phrases such ...

  • NICE endorses rivaroxaban for pulmonary embolism

    28 JUN 2013 21:18

    The orally administered anticoagulant rivaroxaban (Xarelto) should be made available on the NHS as an option for treating pulmonary embolism (PE) and preventing recurrent deep vein thrombosis (DVT) and PE after acute PE in adults, the National Institute for Health and Care Excellence has decided.

  • NICE hepatitis B advice tackles under treatment

    28 JUN 2013 21:02

    Hepatitis B patients should no longer be offered adefovir dipivoxil because it is less effective than tenofovir disoproxil and less cost-effective than other treatment strategies, according to the National Institute for Health and Care Excellence.

  • Blister (Dreamstime.com/Berna_Safoglu)

    Controlled Drug guidance for Scotland becomes available

    28 JUN 2013 13:37

    Guidance on Controlled Drugs governance has been produced by NHS Scotland Controlled Drugs accountable officers. It includes a guide for NHS staff and contractors on reporting incidents, near misses and concerns involving Controlled Drugs.

  • Drips in hospitals. (Dreamstime.com/Carmakoma)

    Precautions needed to manage allergies with iron medicines, says EMA

    28 JUN 2013 13:29

    The European Medicines Agency’s Committee for Medicinal Products for Human Use has updated its recommendations on the use of intravenous iron-containing medicines used to treat iron deficiency and anaemia.

  • Acting in the patient’s best interests: how far would you go?

    27 JUN 2013 By Benedict Lam

    As pharmacists we have an obligation always to act in the patient’s best interests. After all, according to the General Pharmaceutical Council’s “Standards of conduct, ethics and performance”, the first principle is “Make patients your first concern”. But just how far are you willing to go to justify your actions?

  • Stressed man. (Dreamstime.com/umahtetes)

    Antisuicidal effects of lithium shown in new study

    27 JUN 2013 15:16

    Patients taking lithium will have an added benefit since the drug has been shown to be an effective treatment for reducing the risk of suicide in those with mood disorders, according to a new study. The drug seems to reduce the risk of death and suicide by more than 60 per cent compared with placebo, finds a systematic review published on BMJ.com today (27 June 2013).

  • Middle aged woman (dreamstime.com/Igor Sokolov)

    Cognitive impairment after HRT not seen in younger women

    27 JUN 2013 10:54

    Younger postmenopausal women do not suffer the same cognitive impairments that older postmenopausal women do after treatment with hormone therapy, a study suggests (JAMA Internal Medicine online 24 June 2013).

  • Medicine being poured out of a bottle into spoon (Dreamstime.com/IrynaRasko)

    MHRA considers inspecting specials firms; Temag defends itself

    26 JUN 2013 15:03

    The Medicines and Healthcare products Regulatory Agency says it will consider inspecting the three specials manufacturers allegedly involved in defrauding the NHS through misleading pricing practices. The firms’ activities were brought to light after a Daily Telegraph investigation.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.